Notices. A notice of issuance of Final Guidance Publication was published in the **Federal Register** June 27, 2012, (77 FR 38297)
148 words·~1 min read·
/register/2012/07/12/2012-17002A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket Number NIOSH-190] Revised Document Posted: NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012, Correction AGENCY: National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: A notice of issuance of Final Guidance Publication was published in the **Federal Register** June 27, 2012, (77 FR 38297).
This notice is corrected as follows: On page 38297, the Docket number has been changed to NIOSH-190. FOR FURTHER INFORMATION CONTACT: Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 4676 Columbia Parkway, MS-C26, Cincinnati, OH 45226, Telephone
(513)533-8132, email *hazardousdrugs@cdc.gov* . Dated: July 6, 2012. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 2012-17002 Filed 7-11-12; 8:45 am]